Safety and Efficacy of Glibenclamide Combined With Rt-PA in Acute Cerebral Embolism
A phase 2/3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 306 participants.
Also called NCT03284463
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase
- Phase 2/3
- Enrolled
- 306 participants
- Registry
-
NCT03284463
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- China
- Registry status
- Completed
Technical summary
Registry record NCT03284463. Randomized; quadruple masking; primary purpose treatment. Start 2018-01-01 (actual); primary completion 2022-08-28 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Safety and Efficacy of Glibenclamide Combined With Rt-PA in Acute Cerebral Embolism
- Acronym
- SE-GRACE
- Condition
- Acute Stroke
- Intervention (Drug)
- Glibenclamide
- Intervention (Drug)
- Placebo
- Lead sponsor
- Nanfang Hospital, Southern Medical University
Record details
- Record id
cardio:ct-nct03284463- Content hash
25e49a3b814301e9c297314b3c3b2dbc81949ee1aa1d8103319ea70b16d3da47